ABL is pleased to announce the allowance of a new patent covering new Hepatitis B primers and kits hybridizing to DNA or mRNA of the Hepatitis B Virus Polymerase gene.
ABL-EVIVAR Obtains New Patent Allowance on Hepatitis B Virus Polymerase Gene
Dec 19, 2017